Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

DETERMINE: Detemir vs NPH — Stella

Home/Gestational Diabetes/DETERMINE: Detemir vs NPH

View on ClinicalTrials.gov

Recruiting

Back to Gestational Diabetes trials

DETERMINE: Detemir vs NPH

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

University of California, Los Angeles, Los Angeles, California

Key details

Phase

Safety & dosing

Sponsor

University of California, Los Angeles

Enrollment target

~336 participants

Started

February 2022

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated September 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.